There has been a considerable debate as to whether caspase-2 is an initiator or effector caspase. Recently, a new model of intrinsic pathway of apoptosis has been proposed, which suggests caspase-2 to be an initiator caspase. For example, ultraviolet radiation (UV) and other DNA damage-inducing agents were shown to first activate caspase-2 and then regulate the mitochondrial and postmitochondrial events. Active caspase-2 was found to engage mitochondria by promoting Bax translocation to the mitochondria. Consequently, Bax was proposed to play a central role in bridging the active caspase-2 with mitochondria by affecting mitochondrial permeability, cytochrome c release into the cytosol and caspase-9 activation. In the present study, we investigated the role of Bax in UV-induced apoptosis and caspase-2 activation. Our results indicate that UV-induced apoptosis and caspase-2 activation were diminished in Bax-deficient cells, suggesting that Bax appears to play an important role in UV-induced apoptosis as well as caspase-2 activation, and that it also appears to reside upstream of caspase-2. Bax deficiency also affected the activation of caspase-3 and -8 and abolished caspase-9 activation during UV-induced apoptosis, suggesting that the absence of caspase-9 activation may affect caspase-2, -3 and -8 activation in Bax-deficient cells. Based on our results, we propose that activation of caspases is not a linear cascade of events, but is rather connected via complex feedback loops.
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Oncogene ( Keywords: caspase-2; ultraviolet radiation; Bax deficiency; colon cancer cells Caspases are a family of cysteine proteases that are important for mediating apoptotic signals. In general, they are grouped as initiator and effector (executioner) caspases (Thornberry et al., 1998; Hengartner, 2000) . Initiator caspase-8 and -10 mediate apoptotic signals originating at the membrane death receptors and, upon activation, they cleave and activate downstream effector caspases such as caspase-3, -6 and -7 (reviewed in Schulze-Oshkenazi et al., 1998; Ashkenazi et al., 1999; Sheikh and Fornace, 2000) . Caspase-9 is another initiator caspase that is linked to the activation of the mitochondrial pathway. Upon activation, caspase-9 also cleaves and activates the downstream effector caspases including caspase-3, -6 and -7 (reviewed in Gross et al., 2000) .
Although caspase-2 is among the first mammalian caspases to be identified, there has been considerable debate as to whether it is an initiator or effector caspase (Wang et al., 1994; Harvey et al., 1997; Slee et al., 1999; Paroni et al., 2001) . Recently, it has been reported that caspase-2 resides upstream of the mitochondria and appears to function as an initiator caspase. For example, it has been reported that DNA damage-inducing agents such as etoposide, cisplatin and ultraviolet radiation (UV), that are believed to predominantly engage the mitochondrial pathway, activate caspase-2, which in turn regulates the mitochondrial and postmitochondrial events including the activation of caspase-9 (Guo et al., 2002; Robertson et al., 2002) . Active caspase-2 was reported to engage mitochondria by promoting Bax translocation to the mitochondria, which was then found to affect the mitochondrial permeability, cytochrome c release into the cytosol and caspase-9 activation. For example, Lassus et al. (2002) used the small interfering RNA (siRNA) approach to silence the expression of endogenous caspase-2, and reported that DNA damage-inducing agents such as etoposide and UV did not promote Bax translocation from the cytosol to the mitochondria. Based on these findings, they concluded that caspase-2 activation was required for Bax translocation to the mitochondria. These results placing caspase-2 upstream of Bax proposed a paradigm shift regarding the role of caspase-2 in promoting apoptosis. Accordingly, a new model of the intrinsic pathway of apoptosis was proposed, suggesting that agents such as UV engaging the intrinsic pathway of apoptosis first activate caspase-2 and then engage mitochondrial and postmitochondrial events (Guo et al., 2002; Lassus et al., 2002; Robertson et al., 2002) . In this regard, the mitochondria were suggested to function as an amplifier of apoptosis and Bax was believed to play a central role in bridging the active caspase-2 with mitochondria. This new model of apoptosis also placed caspase-9 to be downstream of caspase-2, although there are a few earlier reports suggesting caspase-9 to promote caspase-2 activation (Paroni et al., 2001) . Given that the recent findings propose a paradigm shift in our thinking about the activation of intrinsic pathway of apoptosis, particularly in response to DNA damage-inducing agents, additional studies are needed to validate whether indeed caspase-2 functions as an initiator caspase that resides upstream of Bax, mitochondria and caspase-9. We therefore undertook this study to investigate this issue.
We used Bax-proficient (Bax þ /À ) and -deficient (Bax À/À ) HCT116 human colon cancer cells that are isogenic, except for the presence and absence of Bax (Zhang et al., 2000) . First we investigated UV-induced apoptosis in these cells and, as shown in Figure 1 , UV induced apoptosis in Bax-proficient cells as a function of time, with maximal effect noted by 48 h postirradiation. UV-induced apoptosis was considerably reduced in Bax-deficient counterparts, suggesting that Bax was important in mediating the apoptotic effects of UV.
Next, we investigated the effect of Bax deficiency on procaspase-2 processing and activation during UVinduced apoptosis. Previous studies have shown that procaspase-2 activation occurs in two steps. In the first step, a larger 32-33 kDa fragment and a smaller 14 kDa fragment are generated; the second step involving further proteolysis generates a fully functional caspase with cleaved fragments ranging in size from 12 to 18 kDa (Li et al., 1997) . First, we evaluated the effect of UV on procaspase-2 processing and, to this end, Baxproficient and -deficient cells were either not exposed or exposed to UV, and approximately 24 h post-UV exposure, cell lysates were prepared and subjected to Western blotting with 11B4 monoclonal anticaspase-2 antibody. We selected this time point since, 24 h following UV exposure, considerable apoptosis can be detected in these cells (Figure 1 ). Further, the antibody used detects procaspase-2 as well as B32 and B18 kDa cleaved fragments of caspase-2. As shown in Figure 2 , the levels of procaspase-2 (B48 kDa) were decreased in UV-treated Bax-proficient cells that were coupled with the appearance of B32 and B18 kDa intermediate and smaller fragments, respectively (this antibody also detects a nonspecific band immediately above the B32 kDa fragment, which is present in untreated and UV-treated samples). In UV-treated Bax-deficient cells, however, the amount of B32 kDa intermediate fragment was significantly less and the smaller cleaved fragment (B18 kDa) was not detected (2). These results suggest that Bax deficiency affects the processing of procaspase-2 during UV-induced apoptosis. We also investigated whether Bax deficiency would affect the processing and activation of other major procaspases including procaspase-8, -9 and -3 during UV-induced apoptosis. As shown in Figure 3 , UV exposure promoted procaspase-8, -9 and -3 processing in Baxproficient cells and, although Bax deficiency appeared to affect the activation of these casapases, its effect was more pronounced on caspase-3 and -9. Next, we directly measured the activities of these caspases in untreated or UV-treated Bax-proficient and -deficient cells. As shown in Figure 4 , UV treatment enhanced the activities of these caspases in Bax-proficient cells, but, in Baxdeficient counterparts, UV-induced activation of caspase-2, -3 and -8 was diminished and that of caspase-9 was abolished.
Cytochrome c release from the mitochondria into the cytosol is a critical event in the activation of intrinsic pathway of apoptosis, since its interactions with Apaf-1 and procaspase-9 promote caspase-9 activation (Wang, 2001) . Our preceding results indicate that caspase-9 activation was abrogated during UV-induced apoptosis in Bax-deficient cells; therefore, we investigated the release of cytochrome c into cytosolic fractions of untreated and UV-treated Bax-proficient and -deficient cells. As shown in Figure 5 , UV induced the release of cytochrome c into the cytosol in Bax-proficient cells, but Figure 1 UV induces apoptosis in Bax-proficient and -deficient human colon cancer cells. Bax-proficient (Bax þ /À ) or -deficient (Bax À/À ) cells were either not exposed or exposed to UV (120 J/m 2 ), and incubated for the indicated time points. Cells were processed for apoptosis detection as we have previously described (He et al., 2002) . The values represent the means of three independent experiments; bars, s.e.m. , and incubated for approximately 24 h. Cells were processed for Western blot analysis using a monoclonal antihuman caspase-2 antibody (11B4, Alexis Biochemicals, San Diego, CA, USA). Western blot analysis was performed by standard procedures, as we have previously described (Huang et al., 2001; He et al., 2002) . The same blot was subsequently probed with antib-actin antibody (Sigma, St Louis, MO, USA) to demonstrate comparable loading in each lane. *Corresponds to a nonspecific band Bax deficiency and caspase-2 activation Q He et al not in Bax-deficient cells. These results indicate that the abrogation of UV-induced caspase-9 activation in Baxdeficient cells appears to be due to the lack of cytochrome c release from the mitochondria into the cytosol. These results further indicate that Bax plays an important role in UV activation of the intrinsic pathway, since activation of this pathway is abrogated in Bax-deficient cells. Our results also indicate that although the intrinsic pathway is important during UV-induced apoptosis (as is evident by cytochrome c release into the cytosol and caspase-9 activation in Baxproficient cells), abrogation of this pathway due to Bax deficiency does not completely abolish the UV-induced apoptosis (Figure 1 ). It is likely that the extrinsic pathway also plays a role in UV-induced apoptosis in these cells. Indeed, previous studies by us and others have reported that UV does engage the extrinsic pathway of apoptosis by promoting death receptor oligomerization (Rehemtulla et al., 1997; Aragane et al., 1998; Sheikh et al., 1998; Sitailo et al., 2002 ). Our results demonstrate that UV-induced caspase-2 activation is affected due to Bax deficiency. Thus, although caspase-2 may reside upstream of Bax in some cells, as reported recently, our results reported here suggest that Bax is also needed for full activation of caspase-2. In fact, our preceding results indicate that Bax deficiency affects (to varying degrees) the activation of all caspases tested, including caspase-2, -3, -8 and -9, during UV-induced apoptosis. Given that the activation of intrinsic pathway (including that of caspase-9) is abrogated in Bax-deficient cells, residual activation of caspase-8, -3 and -2 in Bax-deficient cells could reflect the UV activation of the extrinsic (death receptor) pathway. Since caspase-8, the apical caspase in the extrinsic pathway, is known to activate caspase-3, the residual activation of caspase-2 noted in Bax-deficient cells might occur via UV activation of caspase-3 and -8. Alternatively, caspase-2 may function as an initiator caspase and resides upstream of caspase-9. However, it is possible that a feedback amplification loop may exist between caspase-2 and -9, such that active caspase-9 may also participate in the full processing/activation of caspase-2, which may explain the diminished activation of caspase-2 in Bax-deficient cells. To further investigate , and incubated for approximately 24 h. Cells were processed for Western blot analysis using anti-human caspase-8, anti-human caspase-9 (StressGen, Victoria, BC, Canada) and anti-human caspase-3 monoclonal antibodies (BD, Lexington, KY, USA). The same blots corresponding to Baxproficient and -deficient cells were sequentially probed with the indicated antibodies. Western blot analysis was performed by standard procedures as we have previously described (Huang et al., 2001; He et al., 2002) . The same blots were subsequently probed with anti-b-actin antibody (Sigma, St Louis, MO, USA) to demonstrate the comparable loading in each lane Figure 4 Enzymatic activities of caspase-2, -3, -8 and -9 in the lysates of untreated and UV-treated Bax-proficient and -deficient cells. Cells were either untreated or treated with UV (120 J/m 2 ) and incubated for approximately 16 h. Floating and adherent cells were collected and subjected to the caspase activity assay using caspaseselective fluorogenic substrates (ICN, Aurora, OH, USA) including Ac-VDVAD-AFC (caspase-2), Ac-IETD-AFC (caspase-8), Ac-LEHD-AFC (caspase-9) and Ac-DEVD-AFC (caspase-3). The measurement of the fluorogenic substrate cleavage was performed using a modified fluorometric assay, as reported previously (Robertson et al., 2002) . In brief, floating and adherent cells were pooled, centrifuged, and washed with PBS, and cell pellets were dissolved in lysis buffer (50 mM Tris-HCl (pH 7.5), 10 mM NaPPi, 1% Triton X-100 and 150 mM NaCl). Protein concentrations were determined by a Bio-Rad protein assay. For each reaction, approximately 1 ml of the caspase-selective fluorogenic substrate (dissolved in DMSO at 20 mM) was added to a microcentrifuge tube containing 500 ml of assay buffer (100 mM HEPES (pH 7.4), 5 mM DTT, 0.5 mM EDTA, 0.1% CHAPS and 10% glycerol). Equal amounts of protein representing untreated or UV-treated cells were then added to the corresponding tubes and incubated for approximately 30 min at 371C. Liberation of AFC from the fluorogenic substrates (representing caspase activity) was detected by using a spectrofluorometer (FL3-21), with an excitation wavelength of 400 nm and an emission wavelength of 505 nm. The values of caspase-2, -8 and -9 activities represent the means of four independent experiments; the value of caspase-3 activity represents the mean of three independent experiments; bars, s.e.m. these possibilities, we used cell-permeable inhibitors that selectively inhibit caspase-3, -8 and -9. We reasoned that if caspase-2 activation is dependent on the activation of caspase-3, -8 or -9, then inhibition of one or more of these caspases should also inhibit caspase-2 activation during UV-induced apoptosis. As shown in Figure 6 , inhibitors of caspase-3 or -8 blocked caspase-2 activation in both Bax-proficient and -deficient cells, while caspase-9 inhibitor was less efficient. These results suggest that caspase-2 activation during UV-induced apoptosis is also dependent on the activation of caspase-3 and -8, and to a lesser degree on caspase-9 activation.
To the best of our knowledge, the present study is the first to investigate the requirement of Bax for caspase-2 activation during DNA damage-induced apoptosis. Our present results indicate that Bax appears to play an important role in the activation of caspase-2 during UVinduced apoptosis. UV-induced caspase-2 activation was diminished in Bax-deficient cells, suggesting that certain elements of Bax function appear to reside upstream of caspase-2 and are required for its full activation. Our results indicate that caspase-3 inhibition also affects caspase-2 activation in both Bax-deficient and -proficient cells. A simplistic interpretation of these results would be that caspase-3 resides upstream of caspase-2. According to the extrinsic and intrinsic pathways of apoptosis, caspase-3 resides downstream of caspase-8 and -9. Thus, a further simplistic interpretation of our results would be that caspase-8 and -9, by promoting activation of caspase 3, could promote full caspase-2 activation and, therefore, in principle reside upstream of caspase-2. However, Bax deficiency also affects activation of caspase-3, -8 and -9 during UV-induced apoptosis in these cells. It is possible that a mutual feedback amplification loop exists among these caspases such that the complete abrogation of caspase-9 activation in Bax-deficient cells would affect the full activation of caspase-2, -3 and -8. In fact, recent studies have reported the existence of feedback amplification loops among various caspases (Slee et al., 1999; Fujita et al., 2001; Holcik et al., 2001; Cowling et al., 2002) . For example, caspase-8 or -9 is known to activate caspase-3, but active caspase-3 has also been reported to be involved in fully activating caspase-8 and -9 (Slee et al., 1999; Fujita et al., 2001) . Caspase-3 is also reported to be required for full activation of other caspases including caspase-2, -6 and -10 ( Slee et al., 1999; Paroni et al., 2001) . Similarly, caspase-9 has been found to be required for the full activation of caspase-2, -3, -6, -7, -8 and -10 (Slee et al., 1999; Paroni et al., 2001 ). 2 ) and incubated for approximately 16 h. Cytosolic fractions were prepared as previously described (He et al., 2002) . Western blot analysis was performed using a monoclonal anticytochrome c antibody (BD, Lexington, KY, USA). The same blot was subsequently probed with anti-b-actin antibody to demonstrate comparable loading in each lane Figure 6 Effects of caspase-2, -3, -8 and -9 inhibitors on caspase-2 enzymatic activity in UV-treated Bax-proficient and -deficient cells. Cells were either unpretreated or pretreated with the caspase-2, -3, -8 and -9 inhibitors (50 mm each) for 1 h, then were either untreated or treated with UV (120 J/m 2 ) in the presence or absence of the indicated inhibitors for approximately 16 h. Floating and adherent cells were collected and subjected to the caspase-2 activity assay using Ac-VDVAD-AFC caspase-2 selective fluorogenic substrate. The measurement of the fluorogenic substrate cleavage was performed as described in the legend to Thus, based on our present data and the published reports indicating the existence of mutual feedback amplification loops among all these caspases, it seems reasonable to suggest that the activation of caspases is not a linear cascade of events, but rather connected via complex feedback loops (Figure 7) . It is, therefore, possible that caspase-2 may reside upstream of Bax and function as an initiator caspase as recently reported, but, based on our present results, it is also likely that its full activation requires contribution from Bax and other caspases.
